INS and Alzheimer disease: Nevertheless, the features shared by these pathologies (e.g., impaired insulin signaling, and brain glucose transport and metabolism, mitochondrial anomalies, redox imbalance, inflammation and cognitive deficits [20,21]), alongside the failure of most AD clinical trials, led to the hypothesis that antidiabetic drugs may have a therapeutic potential against AD.